Hendrickson elected CHPA board
Perrigo executive assumes Association's lead role
John T. Hendrickson, executive vice president and
general manager, Perrigo Consumer Healthcare, Perrigo
Company, was elected chair of CHPA by the membership at the Association's Annual Executive Conference
March 16-18 in Aventura, Florida. Hendrickson succeeds Timothy G. Hayes,
senior vice president and region head, North America, Bayer
HealthCare LLC, who serves as immediate
Hendrickson was elected to the CHPA Board of Directors
and the Executive Committee in 2004. He was elected vice
chair and appointed Finance Committee chair in 2005.
"We are fortunate to have the benefit of John’s expertise
and experience as CHPA continues its commitment to improved
access to quality healthcare throughout this country," said
CHPA President Linda A. Suydam, D.P.A. "His
dedication and tenacity will serve this Association and the
consumer health industry as well, as we work to expand the
role of over-the-counter medicines and nutritional
supplements in the healthcare arena."
Hendrickson joined Perrigo in 1989 and has held numerous positions of increasing
responsibility from operations to supply chain to sales. Perrigo Company is the world’s
largest manufacturer of private-label OTC medicines and
nutritional products, and is based in Allegan, Michigan.
Prior to attaining his present position at Perrigo, he held
the title of executive vice president of operations. Before
joining Perrigo, he worked for The Procter & Gamble Company
in product and consumer research.
Hendrickson serves on the National Association of Chain Drug
Stores’ Advisory Board and the Michigan Chamber of Commerce
Board of Directors. He also is on the boards of two
charitable organizations that help provide education
and opportunities for youth in southwest Michigan.
Hendrickson received degrees from Hope College and the
University of Michigan, and an MBA from the University of
Virginia Cox and
Elizabeth Assey | Back to the top
elects board and officers
CHPA board directors and officers were elected
during the Association's Annual Executive Conference. John T. Hendrickson, executive vice
president and general manager, Perrigo Consumer Healthcare,
Perrigo Company, was chosen as board chair (See related
article). Timothy G.
Hayes, senior vice president and region head, North
America, Bayer HealthCare LLC, now serves as the
Association’s immediate past chair.
CHPA vice chairs:
Gordon Knapp, president, Consumer Healthcare North America, Pfizer
Patrick M. Lonergan, partner, president, NUMARK Laboratories;
James J. Mackey,
senior vice president, sales/operations, Consumer
Healthcare, Schering-Plough HealthCare Products, Inc.;*
Brian J. McNamara, senior vice president, general manager, OTC North
America, Novartis Consumer Health, Inc.;*
George M. Quesnelle,
president, North America, Consumer Healthcare,
Douglas A. Rogers, president, U.S. Healthcare Division, Wyeth
CHPA board members:
Christopher B. Ascher,
executive vice president, sales and marketing, B.F. Ascher
& Company, Inc.;
Gary R. Downing,
chief executive officer, Lansinoh Laboratories, Inc.;
Scott R. Emerson,
president, The Emerson Group;*
chairman of the board and chief executive officer, Chattem,
vice president, marketing and sales, Consumer Health
Care, Boehringer Ingelheim Pharmaceuticals, Inc.;*
Jeffrey S. Himmel,
chairman and chief executive officer, Himmel
Charles J. Hinkaty,
president and chief executive officer, Del Laboratories,
Carl J. Johnson,
president and chief executive officer, Matrixx
Daniel R. Johnson,
senior vice president, general counsel and secretary,
Richard H. June,
vice president, global personal health, The Procter &
John J. Lewis, president and chief
executive officer, ACNielsen U.S.;*
Peter C. Mann,
chief executive officer and chairman of the board,
Prestige Brands, Inc.;
New York sales manager/drug category manager, Reader’s
Jeffrey M. Nugent,
president and chief executive officer, Insight
Gregory C. Pulido,
chairman and chief executive officer, Humco Holding Group,
senior vice president, marketing and sales, Taro
Pharmaceuticals U.S.A., Inc.;
Michael J. Valentino,
president and chief executive officer, Adams Respiratory
Renaat Van den Hooff,
president, Johnson & Johnson · Merck Consumer
Neill B. Walsdorf,
president, Mission Pharmacal Company;
Colin F. Watts, president, McNeil Consumer & Specialty
Ph.D., president and chief executive officer, The
Mentholatum Company, Inc.;
Tyler F. Young,
president and chief executive officer, W.F. Young,
Ted E. Ziemann,
president, Cargill Health and Food Technologies.
Serving on the board
officio as a committee chair:
Thomas M. Booth,
senior vice president, strategic planning and business
development, Pfizer Inc (International Affairs Committee
William E. Hawxhurst,
vice president and assistant general counsel, Bayer
Healthcare LLC (Government Affairs Committee chair);
Edwin L. Hemwall,
Ph.D., vice president, Global Regulatory Affairs,
Johnson & Johnson • Merck Consumer Pharmaceuticals Co.
(Scientific Affairs Committee chair);
vice president, Global Communications, Bayer HealthCare
LLC (Public Affairs Committee chair);*
Richard C. Norgard,
senior director, Global Manufacturing Compliance, Pfizer
Inc (Manufacturing Controls Committee chair); and
Randy M. Sloan,
senior vice president, general manager, Del
Laboratories, Inc. (Business Development Committee
*denotes newly elected to
CHPA contacts: Virginia Cox and
Elizabeth Assey | Back to the top
Nine new members approved by
CHPA's Board of Directors elected three Active and six Associate members at
its March 16 meeting:
DRJ Group Inc., Encinitas,
California; Robert Miller, president, will
be the primary contact. DRJ produces a topical analgesic, Stopain® Spray, which
is distributed through food, drug, and mass merchandise outlets.
HardToFindBrands, Inc./Bira Corporation, McDonald,
Pennsylvania; Ralph Dadowski,
president and founder, will be the primary contact. The company was established
to help smaller OTC healthcare and personal care product manufacturers
distribute “hard-to-find” products to consumers via e-commerce. Bira Corporation
acquires small brands that have lost distribution, but still have a loyal
customer base. Current products are Deep-Down, a penetrating pain relief rub; Dicarbosil, a calcium-rich antacid; and Kellogg’s Tasteless Castor
Kimberly-Clark Corporation, Roswell, California;
Richard Hansen, director, product safety,
will be the primary contact. Eligible products are Huggies Rash Cream and K-C
Professional Skin Care Antiseptics.
John Geils Consulting,
Stamford, Connecticut, [individual consultant];
John L. Geils, president, will be the
primary contact. Geils was formerly president of Requa, Inc., a CHPA Active
member since 1975. Today he is consulting on a variety of OTC issues, including new
Guideline Healthcare &
Pharmaceuticals (Advanced Analytics, Inc.), New York, New York, [marketing
research and consulting, Rx-to-OTC Switch];
Morris S. Whitcup, Ph.D.,
president, will be the primary contact. A former CHPA member from 1999 to 2003,
the company is a full-service market research and consulting firm specializing
in consumer comprehension research, Rx-to-OTC switches, risk minimization, and
research in support of FDA submissions. It has broad global expertise in
research for new and existing products, and DTC and claims substantiation experience.
Hill Top Research
Corporation, Miamiville, Ohio, [clinical research service];
Joel Ivers, chief executive officer,
will be the primary contact. A former CHPA member from 1975 to 2003, the company
provides clinical research and
microbiology services to the global personal care, pharmaceutical, hospital
product/device, and household product/specialty chemical industries. It has six
clinical sites in the U.S. and Canada, and offers a wide range of services
including safety studies, efficacy trials, and contract research organization
Associates, Inc., Pittsburgh, Pennsylvania, [market research, strategic
business management consulting]; George Ryan,
president, enterprise strategy, will be the primary contact. Management Science
is a diversified information management company that has provided market leaders
services in data management, advanced analytics, and business intelligence and
technology, as well as enterprise strategy consulting for over 40 years.
Innovative solutions transform business practices and assist clients in
effectively managing future business outcomes.
Robert E. Nissen,
Consultant, Madison, New Jersey, [individual consultant];
Robert E. Nissen, principal, will be
the primary contact. Nissen provides business development and licensing
consulting for OTC and specialty Rx brands and technologies, skill at
in-licensing and out-licensing, acquisitions and divestitures, Rx-OTC switches,
partnership development, and alliance management. He also offers support in
identification, evaluation, qualification, negotiation, and commercialization of
new products and business ventures, as well as building innovative platforms to
differentiate brands and accelerate growth in a competitive marketplace.
Sawaya Segalas & Co.,
New York, New York, [individual consultant];
Fuad Sawaya, managing director,
will be the primary contact. The firm is an investment banking boutique,
providing financial services for acquisition and disposal of consumer product
Ted Peterson and
Phyllis Taylor | Back to the top
CHPA celebrates 125 years of
service, unveils its new look
CHPA's 2006 Annual Executive Conference (AEC) was special for a
number of reasons. Chief among them, the Association commemorated its 125th
anniversary. Over 340 members gathered March 16-18 in Aventura, Florida, to
celebrate the milestone.
The Association further capitalized on its birthday by unveiling a new logo at
the meeting. The new design was developed to better capture the prominent role
of CHPA members’ products in the lives of consumers. “This milestone anniversary is the ideal time to
introduce a fresh, new look for the Association,” said CHPA President
Linda A. Suydam, D.P.A. “CHPA’s new logo reinforces
the singular consumer focus of the industry and emphasizes the increasingly
prominent role of OTCs and nutritional supplements in the lives of consumers.”
Suydam reassured AEC attendees that despite CHPA's modern
look, the goals of the Association would not change. “We
remain as we were when we were founded in 1881," she stated, "dedicated to promoting the
increasingly vital role of over-the-counter medicines and nutritional
supplements in America's healthcare system through science, education, and
Back to the top
General sessions focus on
evolutions and revolutions
The Annual Executive
Conference (AEC) held March 16-18, featured three informative general sessions
that covered a wide range of issues that directly, or indirectly, have an impact
on the industry. Expert speakers and panelists focused on such topics as the
history of CHPA, the future of healthcare reform, using new tools to market
consumer products, treating consumers as sovereign, and right- versus left-brain
A tribute to industry’s rich history
March 17 morning general session provided an historical look into one
of the oldest trade associations in the country, CHPA. During the
session, which was sponsored by Cargill, and
hosted by Ted Ziemann, president, Cargill Health & Food
Technologies, attendees learned about the
Association's 125 years of
service to consumer healthcare initiatives, as well as its
future challenges and goals.
Ted Ziemann leads the proceedings at the March 17 AEC general session,
sponsored by Cargill.
Interspersed between a fitting video tribute
Association, CHPA President Linda A. Suydam, D.P.A., shared the stage
with present, future, and past CHPA chairs who spoke to the progression of the industry since its
founding in 1881.
Suydam began her remarks by
noting that the Association has
been “an active participant in helping to shape the legislative and regulatory
landscape of our industry and marketplace over the years.” She brought this
thought into perspective by citing
some historical highlights. “In November 1881,” Suydam said, “CHPA was formed
by a small number of companies with a twofold mission: to repeal a Civil War
tax on what were known as ‘proprietary’ medicines and to ensure continued
consumer access to convenient medications.”
The Association helped shape
several subsequent significant regulatory and legislative initiatives in the
time intervening, resulting in increased
quality healthcare options and more confidence in the safety and effectiveness
"We have 125
years of experience and success upon which to draw, and we expect the best is
yet to come.”
— CHPA President
Suydam concluded her remarks by thanking AEC attendees for sharing in the
celebration of the Association's anniversary.
The next to speak was outgoing CHPA Chair Timothy G. Hayes, senior
vice president and region head, North America, Bayer HealthCare LLC, who offered
his perspective on industry’s long-standing commitment to its
consumers, focusing on CHPA’s dedication towards consumer education. Past
efforts, Hayes said, include combined educational initiatives with government
partners such as FDA, as well as the most recent initiative, the Consumer Health
Education Center, launched in October 2005. “Consumer education has a rich
history at CHPA,” commented Hayes, “and its success is the direct result of many
years of dedicated work. I cannot tell you how gratified I am to be part of yet
another exciting advancement.”
Dovetailing Hayes’ remarks on the importance of consumer
education, incoming CHPA Chair John T. Hendrickson,
executive vice president and general manager, Perrigo Consumer Healthcare, spoke
to the significance of the consumer healthcare products industry within the larger
“With more than three-quarters of Americans turning to
OTCs, and millions using them every day, this highly regulated, scientifically
grounded, and essential industry is important to any number of constituencies
across the country.”
— CHPA Chair Hendrickson
Rounding out the tribute to the Association’s past, as well
as its outlook on the future, were presentations by two esteemed former CHPA
Chairs, Charles J. Hinkaty, president and chief executive officer, Del
Laboratories, Inc., and Richard K. Green, board member, Blistex Inc. Based on
their vast leadership experience with the Association, as well as within the
workings of their respective companies, the executives offered thoughts on the
cornerstone of the Association—its membership. “Any Association,”
said Hinkaty, “is only as strong as we, the members, are active and dedicated."
Health experts discuss the role of OTCs in the future of
Former Congressman and Speaker of the U.S. House of
Representatives Newt Gingrich provided attendees of the Cargill general
session with his thought-provoking discussion on “Saving Lives and Saving Money:
Transforming Health and Healthcare in the 21st Century.” Before beginning his
presentation, however, Gingrich told the audience that since his last appearance
at CHPA's 2002 annual meeting, the role of OTC medicines and nutritional
supplements has taken on new meaning in his life, and he now takes these
products daily for preventive reasons. Praising the industry for its
cost-effective efforts to meet many healthcare needs, he added, “You are the
least expensive and most pervasive form of healthcare we have."
Former Speaker of the U.S. House of Representatives Newt Gingrich shares his
thoughts on healthcare reform with AEC attendees.
”The reality of the 21st Century,” continued Gingrich,
“is that there will be more change in scientific knowledge during the next 25
years than there was in the entire last 100 years.” Healthcare, he opined,
has a lot of work to do in order to catch up.
He likened the success of meaningful healthcare reform to that of the
positive impact on consumers’ wallets that resulted from the U.S. Deregulation
of Airlines Act in 1978. Applying this model to a proposal to reduce the soaring
costs associated with today’s healthcare system, he said that implementing a
“Travelocity for drug purchasing” plan would result in a system that would
better capture the price and effectiveness information so that knowledgeable
consumers may comparison shop.
The key to successfully reforming healthcare as we know it,
Gingrich concluded, lies within the successful business models and strategies of
today’s marketplace, rather than the antiquated government-sponsored model
of the past.
Following his discussion, Judy Feder, Ph.D., professor
and dean, Georgetown Public Policy Institute, Georgetown University, and Gail
R. Wilensky, Ph.D., senior fellow, Project HOPE, joined Gingrich to offer their viewpoints
on the daunting task of reforming the nation's healthcare system. Feder
immediately took issue with Gingrich's so-called “Travelocity” model, and reminded her colleague that
the necessity of insurance pools stems from a patient’s inability to predict his or
her future needs. The ideal healthcare system, Feder added, “ensures quality,
access, and incentives to innovations.” Wilensky, who was more optimistic
regarding the possible success of Gingrich's plan, called for a dramatic change
in how this country pays for its medical services, adding that implementing a
system that pays for performance would be a radical but cost-effective
alternative to today’s healthcare reimbursement procedures.
Other concepts debated at the forum included a shift of the Medicaid program to
a voucher-based program, more incentives for health savings accounts, larger tax
credits for the working poor, efforts to address fraud and abuse, and an
insurance mandate for those individuals who can afford coverage.
Applying political campaign techniques to consumer product marketing
The March 17 afternoon general session, sponsored by DPT
Laboratories, Inc., and hosted by Paul H. Johnson, president, focused on how some of the tools and techniques sharpened in political
campaigns translate to the world of consumer product marketing. Three experts,
including Jonathan Spalter, Dewey Square Group; Jed Alpert, Politxt;
and Frank Luntz, Luntz
Research Companies, shared their thoughts during a panel discussion on
During his comments, Spalter
stressed the importance of peer-to-peer validation of products and concepts, the growing role of non-traditional message platforms, and more bottom-up, or
consumer-driven, messaging. As an illustration, he said that the search engine Technorati
tracked an estimated 21 million Internet blogs last year, with 50 million anticipated
by year’s end. Similarly, he noted the greater ability by people to control
what, where, how, and when they view or access information, as illustrated by
the success of a number of comparatively low-cost, Internet distribution-only
video ads (Click here for
a graphic example). Finally, Spalter pointed to significant demographic shifts taking
place, with implications for messaging techniques, such as estimates that one
quarter of Americans will be of Hispanic origin by 2050 and the rise of the
“Millennial Generation,” a population now entering
the voting booth, with little known consumer habits (See related story).
Panelist Frank Luntz (standing) makes a point, while moderator David Skinner,
Jonathon Spalter, and Jed Alpert look on.
Alpert's comments built on the non-traditional
message-platform theme. He explained that cell phones are an excellent marketing
tool because text messages can be sent directly to an individual, allowing them
to take action on themes of importance to them. This is especially true for people in their
teens or twenties. But he also warned that due to the highly personal nature of one’s
cell phone, it makes it a poor option as a medium to shape messages.
Americans want less hassles, more choices, more time, and
more money, stated Luntz. For women, more time leads the way; for men, more money. Building on that
encouraged the audience to think in terms of providing peace of mind as a touchpoint, as opposed to fixing a negative.
Finally, he stressed that language
matters, noting the importance of using examples that demonstrate value in very
The "consumer as sovereign"
The final AEC general session, held March 18, was
sponsored by Information Resources, Inc. (IRI), and hosted by Steven
Johnson, executive vice president and general manager, Healthcare
Solutions Group. One of the highlights of the session was a panel
discussion, moderated by ABC's Sam Donaldson, on the subject of
"the consumer as sovereign."
Steven Johnson welcomes attendees to the final AEC
general session, sponsored by Information Resources, Inc.
In his opening remarks, Donaldson used J.C. Penney's quote, "the customer is always right"
to bridge to
the panel's theme. The veteran Washington, D.C., correspondent kept panelists George Quesnelle, GlaxoSmithKline;
Tom Furphy, Amazon.com; Sunil Garga, Information
Resources, Inc.; and Jonathon Harries, Foote Cone & Belding, on their toes with
questions involving shifts in the shopping experience, media diffusion,
customization, and "is 50 the new 20?"
In his comments, Furphy tied the shopping experience and customization areas
together, by pointing out that Amazon has 100 million customer profiles. These
profiles allow Amazon to target, and sub-target, communication so that it is
more relevant and individualized based on customer preferences and needs.
Garga illustrated the media diffusion and customization points with a nod to the
hardwired device which allows its users to shift their television signal to
wherever they have Internet access, such as laptops, cell phones, handhelds,
etc. With consumers' ability to view, delete, add, or fast-forward content more
easily every day, customizing messages becomes more important.
While media diffusion and message customization are facts, Quesnelle stressed
that it is imperative for consumer healthcare product makers to understand
consumer needs through science that supports their products. Similarly, Harries
stressed the importance of comprehending consumer needs, and encouraged the
audience to think from that consumer viewpoint, and not from a market gap
Donaldson wrapped things up by asking the panelists to pick one favorite
marketing technique to reach consumers effectively.
Relating to consumers one-to-one, and finding those venues, was Quesnelle's
choice, and he pointed to his company's work on
smoking cessation at NASCAR
Harries picked understanding when a consumer is most receptive to receiving a
message, while Furphy stressed interaction. Sharpening the focus on interaction
and bridging from health products to other consumer goods, Garga opined that
video games are a good tool to reach 20-somethings, and experiential marketing
is a good technique for older audiences.
Pink pits automation against
Rounding out this year’s AEC business program was Daniel
Pink, author of A Whole New Mind. Pink’s lively demeanor sparked interest among
the attendees who were looking to learn more about the key elements to the
successful business model of tomorrow.
In a world of Mars versus Venus, Democrats versus
Republicans, introverts versus extroverts, Pink illustrated the often overlooked
division of labor between the abilities of the right hemisphere of the brain
compared to that of the left. As technology advances
and automation begins to replace many aspects of the analytical thinking
process, Pink argued, those professionals who excel at the so-called right-side brain
functionality will continue to excel, and will prove to have greater significance to
business in the long run.
||Author Dan Pink uses a visual aid to help drive home his theory
that individuals who utilize "right-brain" thinking will produce greater
long-term results in the workforce.
According to Pink,
success, or more accurately, larger profit margins, stem from a product’s
engineering and design. In a country where there are more registered cars than
there are registered drivers, Pink said that consumers do not seek out products out of
necessity; rather, they are looking for the next thing that tells a story.
“Margins come from significance, not from utility,” he mused. “Anything that
is routine will disappear from this country.”
Back to the top
AEC breakfast sessions speak
to the generations
Howe explains shifting demographics at Hearst session
Well-known author and demographer Neil Howe
entertained attendees at the March 17 AEC breakfast session, sponsored by
Hearst Magazines, with his perspective and commentary on
the concept of generations. While these groups are most commonly divided
according to age, Howe illustrated that the commonality extends far beyond an
individual's date of birth.
Beginning with the "G.I. Generation," Howe offered his
insight on how this group’s attitudes were influenced by the strong
institutions of their time, which resulted in a profound appreciation for
authority. Following this generation was the smaller, but equally significant,
"Silent Generation." One of the most notable trends among this generation, said
Howe, was its unease
with taking chances in life, gauging ultimate success by working for government
or larger, more stable companies.
Nipping at the Silent Generation’s heels is the "Boomer Generation." Based on a show of
hands, their presence among today’s business leaders is
significant. Ranging in age from 44 to 61, boomers are less active politically
than their parents, replacing that passion with a focus on the quality of life.
“Boomers just don’t buy a briefcase, they buy a briefcase experience," commented
Howe. He termed successful product advertising toward this group as "the art of
non-ism," explaining that it was important to promote what products do not have—no color, no
caffeine, no preservatives—in order to reach this audience.
Sandwiched in between the Boomer Generation and
today’s youth is "Generation X." Howe explained that for the parents of this
generation, “having kids was not as important as living
a good life.” This generation also introduced society to latch-key kids, which
inevitably attributes the Gen Xers focus on pragmatism and individualism.
Howe rounded out his discussion with the "Millennial Generation." This
generation, Howe mused, “inspired parents to become better parents.” One
significant shift was a call for government protection of children, resulting in
debates about a child’s health and welfare at the national level. The Millennial
Generation shares its parents’ values and have become more active politically
than preceding generations.
Halberstam shares his thoughts on how the past impacts
the future at Reader's Digest session
Popular author and historian David Halberstam
headlined the March 18 AEC breakfast session, sponsored by Reader’s Digest. Halberstam offered his perspective on the
generational shifts of the past and the impact such changes have had on present
day. Echoing some of the concepts outlined in Neil Howe’s discussion from the
previous day, Halberstam attributes the most significant change of past years
surrounding “work driven by blue collar muscularity to work driven by
education.” Halberstam’s optimism stems from what he deemed the “educational
superiority” of higher education in this country.
ABC's Orlando Reece (center) listens intently while ABC Correspondent Sam
Donaldson (right) explains his own viewpoints on the impact of generational
For such a distinguished historian, no commentary would be
complete without his perspective on the current war in Iraq. While likening the U.S.
presence in Iraq as “punching a fist in the largest hornets nest,” he has
concerns about finding a fast way to end the war, but is confident that a
suitable solution can be reached. Following his talk, Halberstam opened the
floor up for questions and was greeted by an enthusiastic crowd whose questions
ranged from inquiries on the Patriot Act, professional football scouting, and
his tour in Vietnam.
Back to the top
2006 photo gallery
CHPA staff has put together a photo album of some of the
highlights from the 2006 Annual Executive Conference (AEC). If you
weren't at the meeting, you may want to see what you missed. If you were
there, see if we caught you or your colleagues on camera!
here for 2006 AEC photos.
Back to the top
Social events bring members
CHPA’s 2006 Annual Executive Conference opened with a
fitting tribute to the Association’s 125 years of service to the
OTC medicine and nutritional supplement industries. ACNeilsen sponsored the
opening social networking opportunity with a live production of Neil Goldberg’s
Cirque. The inner child in both young and old was wowed by amazing feats of
acrobatics and agility. Following dinner and the show, a festive balloon drop
and tribute to CHPA’s birthday, complete with a large cake and pyrotechnics, was
sponsored by The Emerson Group. CHPA thanks the sponsors and all AEC attendees
who participated in the celebratory event.
Perrigo and ACNielsen executives clown around with one of the performers from
the Cirque production, sponsored by ACNeilsen.
also sponsored an opportunity for attendees to swap stories poolside,
which preceded an open evening for networking. Saturday
brought a bit more for those attendees who wanted to enjoy some of the south Florida sunshine with an early
Saturday morning fun run and walk sponsored by Prevention Magazine.
Following the conclusion of the 2006 business program,
many meeting attendees took advantage of the weather for a round of golf or a match of tennis.
A final, casual, bar-b-cue capped the evening, sponsored by The Fairmont Turnberry Isle Resort & Club.
Back to the top
Back to the top
Once upon a time in healthcare history...
The following events occurred during this two-week span in history:
|March 14, 1936:
|The first edition of the Federal Register
|March 26, 1953:
|Jonas Salk introduces his polio vaccine.
|March 23, 1982:
|FDA approves the Rx-to-OTC switch of miconazole
nitrate as a topical antifungal.
|March 17, 1999:
|FDA issues its final "Drug Facts"
labeling regulation for
Back to the top
Coming this summer: FDA/industry workshops
Two dates and locations provide two great opportunities to attend this
essential educational collaboration between FDA and industry.
June 23, 2006
July 20, 2006
Hyatt Regency Chicago
Be sure to mark your summer
calendar for the FDA/industry workshops. Additional information
will follow in future issues of the Executive Newsletter.
CHPA contact: Fred Razzaghi | Back to the top
CHPA on the Road
CHPA staff travel inside the
Beltway and beyond
CHPA's Acting Vice President of Regulatory and Scientific Affairs Lorna C.
Totman, Ph.D., was on Capitol Hill March 14 to attend a Poison Prevention
Week Council (PPWC) ceremony in which the council presented U.S. Senator Michael
DeWine (R-Ohio) with the 2006 Friend of the Council Award. During the award
ceremony, DeWine was praised for his longtime advocacy of poison prevention
efforts. The event was held prior to the observance of
Poison Prevention Week (See
March 10 XNL)...
*Photo courtesy of Poison Prevention Week Council
Attendees of the PPWC award ceremony from left: Patricia Adkins, Home Safety
Council; Nychelle Fleming, CPSC; Nancy Bock, The Soap and Detergent Association;
U.S. Senator Mike DeWine; Lorna Totman, CHPA; Anne Flanagan and Elena Juris,
American Association of Poison Control Centers; and Former U.S. Senator David
CHPA's Associate Director of Scientific Affairs Marcia D. Howard, Ph.D.,
attended the 45th Annual Society of Toxicology Meeting and ToxExpo March 5-9 in
San Diego, California. Various aspects of toxicology were
addressed during the symposia...
Back to the top
Federal Agency Update
Bush nominates von Eschenbach
as FDA commissioner, Boyer to head Agency's legislative affairs
George W. Bush issued a
personnel announcement announcing his nomination of Andrew C.
von Eschenbach, M.D., as commissioner of FDA. von Eschenbach has been
serving as acting commissioner of the Agency since the departure of
Lester M. Crawford, D.V.M., last September (See
September 30, 2005, XNL). In addition to handling his
responsibilities at FDA, von Eschenbach also has been serving as director of the
National Cancer Institute, a position he has held since January 2002.
U.S. Department of Health and Human Services (HHS)
Secretary Michael O. Leavitt, issued a
press release expressing his
support for the nomination. "Andy is an inspired choice to provide permanent
leadership at this critical agency," said Leavitt. "His career has been defined
by his vision for progress in research and passion for the care of patients—two
qualities which will serve the Agency and the American public well."
In other FDA news, von Eschenbach issued a
March 15 announcing the appointment of David W. Boyer as the Agency's
assistant commissioner for legislation. In addition to
managing FDA's Office of Legislation, Boyer is responsible for overseeing the drafting of
congressional testimony, responding to congressional inquiries, and assisting in the
development of public health legislation. He also will work closely with FDA's Office of the Commissioner and the Agency centers.
Boyer has held a number of positions at HHS, most recently serving as the special assistant for oversight in the office of the assistant secretary for
legislation. He took over his new role at FDA March 20, replacing Patrick Ronan,
who now serves as the Agency's chief of staff.
Back to the top
FDA's Science Board advisory
committee meets on drug safety
FDA announced a
meeting of its Science Board advisory committee in the March 15 Federal
Register. The public meeting will be held March 31 from 8:00 a.m. to 4:00
p.m. at FDA's office in Rockville, Maryland. According to FDA, the meeting has
been scheduled to allow
the Science Board to continue its discussion on drug safety, initiated during a
November 4, 2005, meeting, and to review FDA's science programs. Additional
topics to be discussed include the science priorities of the Agency's Office of
Women's Health. Written submissions and requests to present at the meeting
should be directed to FDA's Jan
Johannessen by March 24.
CHPA contacts: Fred Razzaghi | Back to the top
advisory committee meeting cancelled
FDA issued a
notice in the March 17 Federal Register canceling the April 18-19
meeting of the Manufacturing Subcommittee of its Advisory Committee for
Pharmaceutical Science. The subcommittee was slated to discuss current
activities of the International Conference on Harmonisation (ICH),
discuss future ICH quality topics, and address current Good Manufacturing
Practice (cGMP) approaches to process validation. No new meeting date has been
CHPA contacts: Fred Razzaghi |
Back to the top
UN drug commission adopts
resolution to fight diversion of precursor chemicals
The United Nations Commission
on Narcotic Drugs (CND) adopted a resolution March 17 that calls for
voluntary international cooperation in the control of pseudoephedrine and other
precursor chemicals used in the illicit manufacture of synthetic drugs, such as
methamphetamine. The CND is the central policy-making body within the United
Nations that assesses the global drug situation and develops proposals to
strengthen the international drug control system. The resolution, which was
proposed by the United States and sponsored by a number of other nations,
includes several provisions aimed at curbing the diversion of precursor
According to a March 17
released by the Office of National Drug Control Policy in support of the CND's
efforts, provisions in the resolution include:
Countries are requested to provide annual estimates to the International
Narcotics Control Board (INCB) of legitimate requirements for piperonyl methyl ketone
(PMK), pseudoephedrine (PSE),
ephedrine (EPH), and phenylacetone (P2P), as well as pharmaceutical preparations containing these
Countries are urged to provide information to the INCB on all shipments of
PMK, PSE, EPH, and P2P, as well as pharmaceutical
preparations containing these substances.
Countries are requested to allow the INCB to share shipment information on
pharmaceutical preparations containing these substances with concerned law
enforcement and regulatory authorities.
Countries are asked to ensure that imports of these substances and
preparations containing these substances are commensurate with legitimate
Back to the top
CHEC update: AARP offers OTC
facts, PR efforts recognized
Working in cooperation with
the Consumer Health Education Center (CHEC), AARP now offers
Over-the-Counter Drug Fact Labels, an article that provides a
primer on the OTC Drug Facts label and tips for using these important
medications safely. CHEC is CHPA’s nonprofit educational foundation dedicated to
providing consumers with information on the safe and effective use of OTCs.
Separately, CHEC’s PR efforts to promote its inaugural campaign, the Doctor in
the House, have been recognized with a nomination for a silver Sabre Award in
the “consumer health” category. The Doctor in the House campaign focuses on
providing women, often the caregivers of the family, information on OTC safety.
Sabre Awards winners will be announced in May.
If you are interested in becoming more actively involved in
CHEC’s work on behalf of consumers, contact
Virginia Cox at (202) 429-9260.
Back to the top
NHCOA holds annual conference
The National Hispanic Council on Aging (NHCOA)
is hosting its annual conference April 7-9 in Miami, Florida. The three-day
meeting will feature a series of workshops and presentations by political,
academic, and corporate speakers on such topics as maximizing retirement
security, addressing diabetes and other health disparities, and outlining policy
for the nation's Latino elderly. The conference also will feature a community
walk, awards dinner, and an exposition, which is free and open to the public.
The exposition, entitled "Plaza del Intercambio: A Resource Exchange," will
provide businesses, government agencies, and nonprofit organizations the
opportunity to showcase products and services to Latino seniors and their
families. Program and registration information for the conference is available
Back to the top
Supply Side East is set for
Virgo Publishing is hosting its annual Supply Side
East international trade show and conference May 1-3 at the Meadowlands
Exposition Center in Secaucus, New Jersey. The event features an educational
program with speakers from government, academia, and industry, who will focus on
a variety of topics, including the benefits of vitamin D, the benefits and risk
of co-branding ingredients, and dietary supplement quality concerns. Supply Side
East also offers an exhibit hall with hundreds of ingredient suppliers and
manufacturing service providers; a seminar on
product-specific science, formulation, and marketing, and four networking
events. Additional information is available
Back to the top
Director of validation,
quality assurance positions available
The following career opportunities
are currently featured on CHPA's members-only Job Board:
Director of validation: A global healthcare supplier and OTC medicine
and nutritional products manufacturer located in the midwestern United
States is seeking a qualified candidate to oversee the company's strategic
direction and execution of validation. Responsibilities include planning and
managing process, cleaning, packaging, and computer validation activities
for all OTC and abbreviated new drug application products; ensuring
compliance with FDA regulations at all company facilities; evaluating
product quality through validation studies; and developing sampling methods
to conduct statistical analysis of test results and process and cleaning
validation studies. Candidates must have 10-15 years of management
experience in validation or technical operations in the pharmaceutical
industry. A bachelor's degree in chemical engineering, mechanical
engineering, chemistry, pharmacy, or a closely related field is required.
Contact: Mary Payne.
Director of quality assurance: A global healthcare supplier and OTC
medicine and nutritional products manufacturer located in the midwestern
United States is looking for a qualified individual to directly supervise
the company's quality assurance (QA) activities in several locations
including: QA review and release, QA components inspection, quality
engineering, document control, consumer affairs, internal auditing, current
Good Manufacturing Practice training, and QA development auditing. The
position also provides supervision of the company's QA development auditing
program, which includes the review of all R&D developmental and clinical
activities. Candidates must have at least 15 years of pharmaceutical quality
management experience, including 5 years supervising a group of 50 or more.
An advanced degree in chemistry, biology, or biochemistry is preferred.
Contact: Mary Payne.
Back to the top